title: PIK3CA genotype and treatment decisions in human epidermal growth factor receptor 2-positive breast cancer.
authors.affiliation: Princess Margaret Cancer Centre, University Health Network, University of Toronto, and Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada.
authors.forename: David W
authors.initials: DW
authors.lastname: Cescon
authors.affiliation: Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada philippe.bedard@uhn.ca.
authors.forename: Philippe L
authors.initials: PL
authors.lastname: Bedard
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D005260:Female; D006801:Humans; D009154:Mutation; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D019869:Phosphatidylinositol 3-Kinases; D018719:Erb-b2 Receptor Tyrosine Kinases